NCT01282970 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 135585 XX in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01277523 Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma Status COMPLETED Phase PHASE3
NCT01276990 Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 in Healthy Male Volunteers. Status WITHDRAWN Phase PHASE1
NCT01276327 Bioequivalence of a Fixed Dose Combination Tablet Linagliptin/Pioglitazone Compared With Its Mono-components Status COMPLETED Phase PHASE1
NCT01276288 Pharmacodynamics and Pharmacokinetics of Empagliflozin and Torasemide in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE1
NCT01271725 LUX-Breast 2; Afatinib in HER2 (Human Epidermal Growth Factor Receptor)-Treatment Failures Status COMPLETED Phase PHASE2
NCT01257230 Efficacy and Safety of 2 Doses of Tiotropium Via Respimat Compared to Placebo in Adolescents With Moderate Persistent Asthma Status COMPLETED Phase PHASE3
NCT01251653 A Phase I Dose Escalation Trial of Afatinib Plus Gemcitabine or Plus Docetaxel Status COMPLETED Phase N/A
NCT01248364 A Study to Determine Acute (After First Dose) and Chronic (After 28 Days) Effects of Empagliflozin (BI 10773) on Pre and Postprandial Glucose Homeostasis in Patients With Impaired Glucose Tolerance and Type 2 Diabetes Mellitus and Healthy Subjects Status COMPLETED Phase PHASE2
NCT01243424 CAROLINA: Cardiovascular Outcome Study of Linagliptin Versus Glimepiride in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT01243268 A Regulatory Requirement Post-Marketing Surveillance Study to Monitor the Safety and Efficacy of Twynsta (Telmisartan + Amlodipine SPC, q.d.) in Korean Hypertensive Patients Requiring Combination Therapy Status COMPLETED Phase N/A
NCT01242176 Relative Bioavailability of Empagliflozin (BI 10773) (Final Formulation) Compared to Empagliflozin (BI 10773 XX) (Trial Formulation 2) in Healthy Male and Female Volunteers Status COMPLETED Phase PHASE1
NCT01241539 Pharmacokinetics of Dabigatran Etexilate (Pradaxa®) During Haemodialysis Status COMPLETED Phase PHASE1
NCT01233284 Randomised, Double- Blind, Cross-over Efficacy and Safety Comparison of Three Different Doses of Tiotropium Administered Once Daily Versus Placebo in Patients With Moderate Persistent Asthma. Status COMPLETED Phase PHASE2
NCT01227629 PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin Status COMPLETED Phase PHASE2